EichorEICHOR
Condition: Chronic Rhinosinusitis With Nasal Polyposis Synced from ClinicalTrials.gov · August 03, 2026

Recruiting studies: Chronic Rhinosinusitis With Nasal Polyposis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Polysomnographic Findings in Nasal Polyposis
NA · 1 location(s) · University Hospital, Lille · NCT03725956Paclitaxel-Coated Balloon Treatment of Chronic Rhinosinusitis
NA · 10 location(s) · Airiver Medical, Inc. · NCT07290140Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Witho
Phase 3 · 21 location(s) · Optinose US Inc. · NCT06850805Biologics in Chronic Rhinosinusitis With Nasal Polyposis
Phase 4 · 2 location(s) · Medical University of South Carolina · NCT06824649Biomarkers of Response to Mepolizumab Treatment in Patients With Nasal Polyps With or Without Bronchial Asthma
Phase N/A · 2 location(s) · Aristotle University Of Thessaloniki · NCT05708300Efficacy and Safety of SHR-1905 Injection in Subjects With Chronic Rhinosinusitis With Nasal Polyps
Phase 3 · 1 location(s) · Guangdong Hengrui Pharmaceutical Co., Ltd · NCT07132827A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal
Phase 3 · 202 location(s) · Eli Lilly and Company · NCT06338995Real Life Study of Biologicals in Patients With Severe CRSwNP
Phase N/A · 1 location(s) · University Hospital, Ghent · NCT05938972Implementation of a Joint Pulmonologist and ENT Consultation in the Care Pathway of Patients Suffering From Asthma and C
NA · 1 location(s) · Assistance Publique Hopitaux De Marseille · NCT07134686Olfactory Outcomes of Dupilumab Treatment for Nasal Polyposis
Phase 4 · 1 location(s) · London Health Sciences Centre Research Institute OR Lawson R · NCT04869436Tapering of Biologics in Chronic Rhinosinusitis With Nasal Polyps
Phase 4 · 9 location(s) · Rigshospitalet, Denmark · NCT07187583A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Wit
Phase 1/Phase 2 · 12 location(s) · Bambusa Therapeutics · NCT07436949A Study to Investigate the Clinical Outcome and Quality of Life in Chinese Post-operative CRSwNP Patients
Phase N/A · 18 location(s) · AstraZeneca · NCT07446738Olfactory Cleft Obstruction and Electrophysiological Field Potentials Predict Olfactory Restoration by Dupilumab in CRSw
Phase N/A · 1 location(s) · Northwestern University · NCT06892704Effect of Full-House ESS With Nasopharyngeal Lymphoid Tissue Ablation on Nasal Polyps
NA · 1 location(s) · Tongji Hospital · NCT07245329Identifying Predictors Of Response To Mepolizumab In CRSwNP
Phase 4 · 1 location(s) · Centre hospitalier de l'Université de Montréal (CHUM) · NCT05902325A Study to Investigate NPS and Symptoms in Chinese Adult Participants With CRSwNP Initiating Treatment With Tezepelumab
Phase 3 · 33 location(s) · AstraZeneca · NCT075201623D Printing to Improve Nasal Irrigation Outcome
NA · 1 location(s) · Ohio State University · NCT06118554Sinonasal Microbiome Transplant as a Therapy for Chronic Rhinosinusitis (CRS).
Phase 2/Phase 3 · 1 location(s) · Region Skane · NCT07184684Dupilumab Treatment Effects in an Ethnically Diverse Population With Chronic Rhinosinusitis With Nasal Polyposis
Phase N/A · 1 location(s) · Montefiore Medical Center · NCT05246267Effect of Dupilumab on Nasal Epithelial Barrier Function in Patients With CRSwNP
Phase N/A · 1 location(s) · Medical University of Vienna · NCT06398873In-clinic Endoscopic Polypectomy for Chronic Sinusitis With Nasal Polyps
NA · 4 location(s) · Ottawa Hospital Research Institute · NCT02975310BIOlogics in Severe Nasal POlyposis SurvEy.: a French Registry
NA · 2 location(s) · University Hospital, Lille · NCT06501807Moving Towards Precision Medicine in United Airways Disease: Unraveling Inflammatory Patterns in Asthmatic Patients With
NA · 1 location(s) · Medical University of Vienna · NCT05009758Prospective, Non-interventional Single-arm Study With Tezepelumab to Investigate the Change in Clinical and Patient-repo
Phase N/A · 8 location(s) · AstraZeneca · NCT07633158CRS Questionnaire Validation Project
Phase N/A · 32 location(s) · The European Forum for Research and Education in Allergy and · NCT06970977Upper Airway Inflammation and Olfaction: Mechanisms of Loss and Recovery
NA · 1 location(s) · Cliniques universitaires Saint-Luc- Université Catholique de · NCT06776042Long-term Safety and Efficacy of TQH2722 Injection in the Treatment of Chronic Sinusitis With or Without Nasal Polyps
Phase 2 · 28 location(s) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06439381Cognitive and Immunologic Profiles of Patients With Olfactory Dysfunction After Smell Training
NA · 1 location(s) · The Cleveland Clinic · NCT07681973Efficacy and Safety of Fully Resorbable Sinus Drug-eluting Stents in Patients With Eosinophilic Chronic Rhinosinusitis W
NA · 1 location(s) · Tang-Du Hospital · NCT07498374
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.